ISEMBYLD Trademark
Trademark Overview
On Thursday, May 29, 2025, a trademark application was filed for ISEMBYLD with the United States Patent and Trademark Office. The USPTO has given the ISEMBYLD trademark a serial number of 99208503. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, May 26, 2026. This trademark is owned by Scholar Rock, Inc.. The ISEMBYLD trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development in the field of therapeutic and diagnostic products
Patient and caregiver support services, namely, providing medical information relating to spinal muscular atrophy (SMA), apitegromab preparations, and drug access
Monoclonal antibodies for medical purposes; pharmaceutical preparations, namely, antibodies for the treatment of spinal muscular atrophy (SMA); therapeutic preparations comprising apitegromab, being a monoclonal antibody for the treatment of spinal muscular atrophy (SMA), musculoskeletal disorders, neuromuscular diseases and disorders, genetic diseases and disorders, and neurological diseases and disorders; therapeutic agents and pharmaceutical preparations for the treatment of musculoskeletal disorders, neuromuscular diseases and disorders, genetic diseases and disorders, and neurological diseases and disorders
General Information
| Serial Number | 99208503 |
| Word Mark | ISEMBYLD |
| Filing Date | Thursday, May 29, 2025 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, May 26, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, May 26, 2026 |
Trademark Statements
| Goods and Services | Research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development in the field of therapeutic and diagnostic products |
| Indication of Colors claimed | The color(s) green is/are claimed as a feature of the mark. |
| Goods and Services | Patient and caregiver support services, namely, providing medical information relating to spinal muscular atrophy (SMA), apitegromab preparations, and drug access |
| Description of Mark | The mark consists of "ISEMBYLD" in green letters with a green wedge cap above the "M". |
| Goods and Services | Monoclonal antibodies for medical purposes; pharmaceutical preparations, namely, antibodies for the treatment of spinal muscular atrophy (SMA); therapeutic preparations comprising apitegromab, being a monoclonal antibody for the treatment of spinal muscular atrophy (SMA), musculoskeletal disorders, neuromuscular diseases and disorders, genetic diseases and disorders, and neurological diseases and disorders; therapeutic agents and pharmaceutical preparations for the treatment of musculoskeletal disorders, neuromuscular diseases and disorders, genetic diseases and disorders, and neurological diseases and disorders |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 29, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 29, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 29, 2025 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Scholar Rock, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142
US |
| Party Name | Scholar Rock, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142
US |
Trademark Events
| Event Date | Event Description |
| Thursday, May 29, 2025 | NEW APPLICATION ENTERED |
| Thursday, May 29, 2025 | APPLICATION FILING RECEIPT MAILED |
| Friday, July 11, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, July 11, 2025 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Friday, October 17, 2025 | ASSIGNED TO EXAMINER |
| Thursday, October 23, 2025 | NON-FINAL ACTION WRITTEN |
| Thursday, October 23, 2025 | NON-FINAL ACTION E-MAILED |
| Thursday, October 23, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, December 16, 2025 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Tuesday, December 16, 2025 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Thursday, April 16, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, April 16, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, April 16, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, April 30, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 20, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 26, 2026 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 26, 2026 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
